| HOME >> MEDICINE >> TECHNOLOGY |
$
0.31$
0.28$
0.58$
0.59Diluted
$
0.30$
0.28$
0.57$
0.57Weighted average shares used in per share calculations:Basic57,14159,84257,66059,720Diluted58,08461,23258,61261,096The following table presents details of the share-based compensation expense that is included in each functional line item in the condensed consolidated statements of income above (in thousands): Three Months EndedSix Months EndedJune 30,July 2,June 30,July 2,2012201120122011Cost of goods sold
$
171$
135$
330$
281Selling, general and administrative3,1133,1326,0565,647Research and development7498741,4511,646Total
$
4,033$
4,141$
7,837$
7,574
MASIMO CORPORATIONCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited, in thousands) June 30, July 2, 20122011Cash flows from operating activities:Net income including noncontrolling interest
$
33,534
$
35,063
3,9733,840Share-based compensation
7,8377,574Provision (benefit) for doubtful accounts
(216)92Provision for obsolete inventory
533850Provision for warranty costs
1,2221,334Benefit from deferred taxes
(319)—Income tax benefit from exercise of stock options granted prior to January 1, 2006
1381,058Excess tax (deficit) benefit from share-based payment
arrangements
285(89)Changes in operati
'/>"/>
| SOURCE Masimo Corporation Copyright©2012 PR Newswire. All rights reserved |